Home| Features| About| Customer Support| Request Demo| Our Analysts| Login
Gallery inside!
Markets

Stocks Making the Biggest Premarket Moves: Jd, the New York Times, Iovance and More

December 28, 2023
minute read

Here are the notable developments in companies making headlines before the opening bell:

Tesla:Tesla, the electric vehicle manufacturer, witnessed a nearly 1% increase, building on previous gains. This surge comes in response to news of the company's plan to overhaul its Model Y vehicle. According to a Bloomberg News report, Tesla intends to initiate the refresh of the model from its Shanghai plant, with the process set to commence in the middle of the next year.

Tencent, Netease:Chinese internet stocks Tencent and Netease experienced gains of 1.9% and 2.5%, respectively. This positive movement follows a commitment from China's top gaming regulator to "further modify and improve" new guidelines addressing excessive gaming. The regulatory assurance contributed to the upward trajectory of these stocks.

New York Times Company:Shares of the New York Times Company continued their upward momentum, posting a 1.3% increase on Thursday. This positive trend follows the media company's filing of a lawsuit against Microsoft and OpenAI, the creator of ChatGPT. The New York Times Company has accused the tech firms of copyright infringement and unauthorized use of its intellectual property for training chatbots.

Coherus BioSciences:The biopharmaceutical stock Coherus BioSciences saw a decline of 2.6% after registering an impressive 23% surge during Wednesday's trading session. The significant rise in Coherus' shares occurred following the approval by the U.S. Food and Drug Administration (FDA) of Udenyca Onbody. This on-body injection system is designed for chemotherapy patients to prevent infections.

Iovance Biotherapeutics:Shares of biotech company Iovance Biotherapeutics rebounded by 3.3% in early morning trading on Thursday. This recovery follows a nearly 19% dip in the stock on Wednesday after the FDA placed a hold on Iovance's LN-145 trial for non-small cell lung cancer.

JD.com:Chinese e-commerce giant JD.com witnessed a premarket trading surge of more than 3% in the U.S. This increase came after a Wednesday night report from Bloomberg News, stating that JD.com is planning salary increases for its front-line staff. The news of pay raises contributed to the positive movement of JD.com's shares.


Tags:
Author
Editorial Board
Contributor
Eric Ng
Contributor
John Liu
Contributor
Editorial Board
Contributor
Bryan Curtis
Contributor
Adan Harris
Managing Editor
Cathy Hills
Associate Editor

Subscribe to our newsletter!

As a leading independent research provider, TradeAlgo keeps you connected from anywhere.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Explore
Related posts.